Prevalence of iron deficiency in a total joint surgery population

Waters, Jonathan H.; Johnson, Peter Anto; Yazer, Mark H.

doi:10.1080/10245332.2017.1422687

Cited by 7 publications

(6 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, this did not have an impact on the overall drop in hemoglobin levels and transfusion requirements after elective TJA. In addition, although ferritin levels were significantly different between the two groups, there was no evidence that SARS-CoV-2 IgG The prevalence of iron deficiency in a TJA surgery population was 6% in a study by Waters et al [17], but increased to 37.5% in patients with anemia. Preoperative anemia is strongly associated with increased transfusion requirement [3].…”

Section: Discussionmentioning

confidence: 79%

See 1 more Smart Citation

Preoperative ferritin and hemoglobin levels are lower in patients with a history of COVID-19 but blood loss and transfusion requirements are not increased

Jungwirth-Weinberger

Bendich

Westrich

et al. 2021

Arch Orthop Trauma Surg

View full text Add to dashboard Cite

Introduction A history of COVID-19 (Coronavirus Disease 2019), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may have an impact on hemoglobin and ferritin levels predisposing patients to increased blood transfusion requirements following total joint arthroplasty (TJA). The current study compares ferritin levels, hemoglobin levels, and transfusion rates between SARS-CoV-2 IgG positive and SARS-CoV-2 IgG negative TJA patients. Materials and methods Preoperative ferritin levels, pre- and postoperative hemoglobin levels, postoperative change in hemoglobin, and transfusion rates of 385 consecutive SARS-CoV-2 IgG positive patients undergoing TJA were compared to those of 5156 consecutive SARS-CoV-2 IgG negative patients undergoing TJA. Results Preoperative hemoglobin levels were significantly lower in SARS-CoV-2 IgG positive patients [13.3 g/dL (range 8.9–17.7 g/dL)] compared to 13.5 g/dl (7.3–18.3 g/dL; p value 0.03). Ferritin levels were significantly lower in SARS-CoV-2 IgG positive patients (mean of 106.1 ng/ml (2.1–871.3.3 ng/ml) vs. 123.7 ng/ml (1.4–1985 ng/ml) ( p value 0.02)). Hemoglobin on postoperative day (POD) one, after four–six weeks, and transfusion rates did not differ between the two groups. Conclusion Although preoperative hemoglobin and ferritin levels are lower in SARS-CoV2 IgG positive patients, there was no difference in hemoglobin on POD one, recovery of hemoglobin levels at four—six weeks postoperatively, and transfusion rates after surgery. Routine ferritin testing prior to TJA is not recommended in SARS-CoV-2 IgG positive patients.

show abstract

Section: Discussionmentioning

confidence: 79%

“…The prevalence of iron deficiency in a TJA surgery population was 6% in a study by Waters et al [ 17 ], but increased to 37.5% in patients with anemia. Preoperative anemia is strongly associated with increased transfusion requirement [ 3 ].…”

Section: Discussionmentioning

confidence: 99%

Preoperative ferritin and hemoglobin levels are lower in patients with a history of COVID-19 but blood loss and transfusion requirements are not increased

Jungwirth-Weinberger

Bendich

Westrich

et al. 2021

Arch Orthop Trauma Surg

View full text Add to dashboard Cite

show abstract

“…Some studies in the literature yielded opposite findings about the relationship between IDA and RTHA outcomes. Waters et al 31) studied the prevalence of iron deficiency in a total joint surgery population, where no association was found between simple iron deficiency and any perioperative complications. However only ferritin was considered as a marker for iron deficiency.…”

Section: Discussionmentioning

confidence: 99%

How Does Iron Deficiency Anemia Impact Outcomes following Revision Total Hip Arthroplasty?

et al. 2021

View full text Add to dashboard Cite

Purpose Studies have shown the prevalence of iron deficiency anemia (IDA) increasing worldwide, and currently the literature is limited on the impact of IDA on outcomes following revision total hip arthroplasty (RTHA). Therefore, the purpose of this study was to determine whether IDA patients undergoing RTHA have longer: 1) in-hospital lengths of stay (LOS); 2) medical complications; and 3) costs of care. Materials and Methods A retrospective query of a nationwide administrative claims database was performed. Using Boolean command operations, the study group consisted of all patients in the database undergoing RTHA with IDA; whereas, patients without IDA served as controls. To reduce the effects of confounding, study group patients were matched to controls in a 1:5 ratio by age, sex, and medical comorbidities yielding 92,948 patients with (n=15,508) and without (n=77,440) IDA undergoing revision THA. A P -value less than 0.001 was considered statistically significant. Results IDA patients were found to have significantly longer in-hospital LOS (5 days vs. 4 days, P <0.0001). Additionally, the study showed IDA patients were found to higher incidence and odds of (73.84% vs. 11.77%, OR 5.04, P <0.0001) 90-day medical complications. IDA patients also incurred high 90-day episode of care costs ($25,597.51 vs. $20,085.70, P <0.0001). Conclusion After adjusting for age, sex, and medical comorbidities this study of over 92,000 patients demonstrated IDA is associated with longer in-hospital LOS, complications, and costs of care. Future studies should compare the duration and severity of IDA on outcomes.

show abstract

“…66 Nedostatak željeza najčešći je uzrok anemije u popula ciji bolesnika koji idu na kirurški zahvat. 67,68 Preopera tivna anemija povišava rizik od transfuzije i povećava broj nepotrebnih transfuzija perioperativno. 69 Preope rativna anemija, čak i u blagom obliku, neovisno je po vezana s povišenim postoperativnim morbiditetom i mortalitetom u 30 dana nakon zahvata.…”

Section: Preoperativna Obrada I Kirurški Zahvatiunclassified

Croatian Hematology Society and CROHEM guidelines for the treatment of iron deficiency anemia

Radman

Vodanović

Mandac-Rogulj

et al. 2019

View full text Add to dashboard Cite

Deskriptori SIDEROPENIČNA ANEMIJA-dijagnoza, etiologija, farmakoterapija; ŽELJEZO-manjak, metabolizam, terapijska primjena; SMJERNICE; HRVATSKA SAŽETAK. Anemija uzrokovana manjkom željeza ili sideropenična anemija (SA) važan je javnozdravstveni problem. Gotovo 30% čovječanstva (> 2 milijarde) pati od manjka željeza. Posebno su ugroženi predškolska djeca, trudnice i žene u generativnoj dobi. Liječenje sideropenične anemije nalaže timski rad jer je važno pravodobno otkriti uzrok koji je doveo do gubitka željeza i liječiti anemiju pripravcima željeza. Funkcionalni manjak željeza jest stanje nedovoljne apsorpcije i fiziološkog iskorištavanja željeza, dok su rezerve željeza očuvane ili čak povećane. Ovaj poremećaj tipičan je za anemiju kod kronične bolesti, kronične upalne bolesti, kroničnoga srčanog popuštanja i maligne bolesti. Pri liječenju sideropenične anemije rabimo oralne i parenteralne pripravke željeza. Noviji parenteralni pripravci daju se u visokoj dozi (jedna ili dvije aplikacije), veoma su djelotvorni i sigurni za primjenu.

show abstract

Prevalence of iron deficiency in a total joint surgery population

Cited by 7 publications

References 26 publications

Preoperative ferritin and hemoglobin levels are lower in patients with a history of COVID-19 but blood loss and transfusion requirements are not increased

Preoperative ferritin and hemoglobin levels are lower in patients with a history of COVID-19 but blood loss and transfusion requirements are not increased

How Does Iron Deficiency Anemia Impact Outcomes following Revision Total Hip Arthroplasty?

Croatian Hematology Society and CROHEM guidelines for the treatment of iron deficiency anemia

Contact Info

Product

Resources

About